Synageva Biopharma Corp

CIK 911326 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Synageva Biopharma Corp.

Recent SEC filings

FiledFormAccession number
Feb 16, 2016SC 13G/A0000858744-16-000037
Jul 6, 201515-12G0001193125-15-245194
Jun 29, 201530001571049-15-005382
Jun 24, 2015SC 13D/A0001144204-15-038778
Jun 24, 2015CT ORDER9999999997-15-011113
Jun 23, 201540001209191-15-055574
Jun 23, 201540001209191-15-055573
Jun 23, 201540001209191-15-055579
Jun 23, 201540001144204-15-038750
Jun 23, 2015S-8 POS0001193125-15-231292
Jun 23, 201540001209191-15-055581
Jun 23, 2015S-8 POS0001193125-15-231289
Jun 23, 2015S-8 POS0001193125-15-231324
Jun 23, 2015S-8 POS0001193125-15-231301
Jun 23, 2015S-8 POS0001193125-15-231277
Jun 23, 201540001144204-15-038749
Jun 23, 2015S-8 POS0001193125-15-231310
Jun 23, 201540001209191-15-055578
Jun 23, 2015S-8 POS0001193125-15-231272
Jun 23, 2015S-8 POS0001193125-15-231274
Jun 23, 201540001209191-15-055575
Jun 23, 2015S-8 POS0001193125-15-231298
Jun 23, 201540001209191-15-055580
Jun 23, 2015S-8 POS0001193125-15-231328
Jun 23, 2015S-8 POS0001193125-15-231282